Pulmatrix Inc Stock Nasdaq
Equities
US74584P1030
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 6.07M | Sales 2023 | 7.3M | Capitalization | 6.79M |
---|---|---|---|---|---|
Net income 2022 | -18M | Net income 2023 | -14M | EV / Sales 2022 | -3.4 x |
Net cash position 2022 | 34.77M | Net cash position 2023 | 10.42M | EV / Sales 2023 | -0.5 x |
P/E ratio 2022 |
-0.71
x | P/E ratio 2023 |
-0.48
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Teofilo Raad
CEO | Chief Executive Officer | 54 | 17-05-02 |
Peter Ludlum
DFI | Director of Finance/CFO | 68 | 22-04-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Batycky
BRD | Director/Board Member | 56 | 19-10-31 |
Director/Board Member | 54 | 20-06-22 | |
Todd Bazemore
BRD | Director/Board Member | 53 | 20-09-30 |
1st Jan change | Capi. | |
---|---|---|
-2.49% | 103B | |
+1.75% | 95.28B | |
+1.46% | 22.15B | |
-15.68% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.63% | 16.05B | |
+5.46% | 13.68B | |
+34.30% | 12.17B |